INS and edema: In the current study, our results showed that LPS-induced pulmonary inflammation, pulmonary edema, increase in insulin level and alveolar cell injuries, and LPS-induced reduction of SP-A expression were markedly compromised by GLP-1 analogue liraglutide both in vivo and in vitro.